According to Securities Times Online, Dave Sekera, Chief US Market Strategist at Morningstar, stated on December 17th that he still sees three low-priced stocks as promising in 2025. He believes that Bristol Myers Squibb, with its four-star rating, low valuation, high dividend yield, and market underestimation of its potential for next-generation drugs. Verizon (VZ)， Low valuation, high dividend yield. Although lagging behind AT&T; T， But still optimistic about the transformation of the US wireless industry towards oligopoly and Verizon's long-term profitability. FMC， Five star rating, low valuation, high dividend yield. The company has passed the inventory period and future sales and profits will rebound.
Sekra reviewed some of Morningstar's best and worst stock predictions for 2024. Failed cases include Est é e Lauder (EL), whose stock price fell 45% due to slower than expected sales growth caused by China's economic recovery. Morningstar has lowered its fair value valuation, but still believes that in the long run, the Chinese market will eventually recover. Crispr Therapeutics (CRSP)：  The company was rated as having no economic "moat" and high uncertainty, resulting in a 43% drop in stock price. Despite the slowdown in sales growth, Morningstar remains optimistic about its long-term potential and believes that its stock valuation is undervalued. APA： This is what Sekra considers the most disappointing prediction, with the stock price falling by 25%. The main reasons are the increased uncertainty of Egyptian assets, early termination of North Sea production, and slow progress in Suriname oil field development. Morningstar will cease analyst coverage for this stock.
Successful cases include: Norwegian Cruise Line (NCLH), whose stock price rose by 80% due to low valuation, the company turning losses into profits, and strong booking momentum. Insulet (PODD)， The stock price rose by 65% due to low valuation, good company performance, and potential acquisition opportunities. But currently the stock price has exceeded Morningstar's fair value valuation, it is recommended to consider selling. Fortinet (FTNT)， The stock price rose by 60% due to the company's successful expansion of business and strong growth in the cybersecurity industry.